Want to know more about the design and results of the SINUS-24 and SINUS-52 CRSwNP pivotal studies? Here you can see the video
Related Topics
You May Also Like
- Multiple sclerosis
Unexpected side effects when switching from natalizumab to a biosimilar
- Immunotherapy
Subcutaneously or intravenously?
- Work-related asthma
When the job leads to exacerbations
- Inoperable NSCLC
Efficacy of pembrolizumab in combination with concurrent chemoradiotherapy
- De-escalation strategies
De-escalation strategies – less is more
- Pain and autism
Hurdles to pain treatment for autistic patients
- Advanced NSCLC
MARIPOSA: Combination therapy as the new standard of care for EGFR-mutated NSCLC
- Pathophysiological mechanisms and therapeutic perspectives